亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

In Vivo Production of Small Interfering RNAs That Mediate Gene Silencing

*Abstract: Nobel laureate and Howard Hughes Medical Investigator Dr. Craig Mello and Howard Hughes Medical Investigator Dr. Phil Zamore and colleagues have engineered novel artificial RNA precursors for use in gene silencing in vivo. These novel stem-loop RNA molecules are designed using endogenous miRNA precursors called pre-miRNAs, as templates. Like premiRNAs, their short duplex nature does not activate the IFN response pathway, avoiding unwanted side effects. In addition, because they are based on endogenous precursor molecules, they are recognized and processed by the naturally occurring RNAi processing enzyme Dicer. Unlike pre-miRNA molecules, they contain complementarity to the target mRNA molecule and Dicer processes them into functional siRNA molecules. These functional siRNA molecules result in gene silencing via RISC-mediated cleavage of the target mRNA. In addition, regulatory sequences are operably linked to the precursor molecules allowing for temporal and spatial regulation in vivo. These novel RNA molecules are applicable in cell culture and non-human animals in the form of a vector substrate or transgene. These artificial precursors are ideal for in vivo gene therapy because they are based on naturally occurring gene silencing molecules and are processed accordingly, providing minimum side-effects with maximum gene silencing.

欲了解更多信息，請點擊這裡